dacarbazine has been researched along with entinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blümcke, I; Buslei, R; Eyüpoglu, IY; Fahlbusch, R; Hahnen, E; Lemke, D; Savaskan, NE; Siebzehnrübl, FA; Tränkle, C; Wick, W | 1 |
| Bangert, A; Cristofanon, S; Debatin, KM; Fulda, S; Häcker, S | 1 |
2 other study(ies) available for dacarbazine and entinostat
| Article | Year |
|---|---|
Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275.
Topics: Animals; Antineoplastic Agents; Benzamides; Blood-Brain Barrier; Brain; Cell Adhesion Molecules, Neuronal; Dacarbazine; Disease Models, Animal; Glioma; Hippocampus; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Pyridines; Rats; Rats, Inbred F344; Rats, Wistar; Temozolomide; Tumor Cells, Cultured | 2006 |
Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Benzamides; Blotting, Western; Cell Line, Tumor; Central Nervous System Neoplasms; Cisplatin; Dacarbazine; Doxorubicin; Drug Synergism; Etoposide; Glioblastoma; Histone Deacetylase Inhibitors; Histones; Humans; Microtubules; Pyridines; Temozolomide | 2011 |